CIK 0001533998 · Non-accelerated filer<br>Smaller reporting company
DarioHealth Corp.
Sign in to watch- Ticker
- DRIO
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 452973162
- Phone
- 972-4-770-6377
- Business address
- 322 W 57TH ST. #33B, NEW YORK, NY, 10019
- Former names
- LabStyle Innovations Corp.
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Other events
- D Other Notice of Sales of Unregistered Securities
- D Other Notice of Sales of Unregistered Securities
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Material agreement · Unregistered share sale
- 4 Derivatives Options or other derivatives
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Other events
- 8-K Event Shareholder vote results
- SC 13G Stake Amended Statement of Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Open-market buy Chief Commercial Officer bought 5,000 shares at $0.91 ($4,546)
- 10-Q Report Quarterly Report
- SC 13G Stake Amended Statement of Ownership
- DEF 14A Proxy Proxy Statement
- 8-K Event Delisting notice
- 8-K Event Shareholder rights changed · Bylaws or fiscal year change
- 4 Open-market buy Chief Commercial Officer bought 10,000 shares at an average $0.82 ($8,244)
Page 6 of 46 · 905 filings